Jersey City, August 11, 2026, 04:45 EDT
- Verisk shares closed 5.55% lower at $181.18 after a Delaware court revived its AccuLynx obligations.
- The decline erased about $1.39 billion of market value, nearly 59% of the deal price.
- The $2.35 billion purchase remains subject to Federal Trade Commission clearance.
- Verisk already repaid $1.5 billion of acquisition notes after terminating the agreement.
Verisk Analytics Inc. NASDAQ:VRSK lost 5.55% on Monday after a Delaware judge revived its $2.35 billion AccuLynx acquisition obligations. The shares closed at $181.18 before Tuesday’s premarket session.
The ruling does not close the deal. It requires Verisk to use commercially reasonable efforts to secure antitrust clearance. AccuLynx can also recover direct costs with interest.
The market’s response put a price on that uncertainty. Monday’s $10.64 share decline erased about $1.39 billion, using 130.16 million outstanding shares. That equals 58.9% of the acquisition price.
| Transaction milestone | Date | Investor consequence |
|---|---|---|
| AccuLynx agreement signed | July 29, 2025 | $2.35bn cash purchase |
| FTC second request | Oct. 22, 2025 | Extended antitrust review |
| Verisk termination date | Dec. 26, 2025 | Company treated agreement as ended |
| Acquisition notes repaid | Jan. 6, 2026 | $1.50bn principal returned |
| Delaware opinion | Aug. 7, 2026 | Termination held invalid |
| Next legal step | Pending | Verisk must seek FTC clearance |
The timeline above comes from the court’s opinion and Verisk’s financial disclosures. Vice Chancellor Bonnie David found Verisk’s willful conduct primarily caused the failed closing condition. She ordered specific performance, meaning contractual action rather than only money damages.
Verisk said it disagreed with the decision and was evaluating its options. The company has not disclosed new financing or a revised closing timetable.
| Market measure | Verified value | Derived comparison |
|---|---|---|
| Aug. 7 close | $191.82 | Reference price |
| Aug. 10 close | $181.18 | -5.55% |
| Session range | $178.62-$187.31 | 4.9% low-to-high span |
| Market capitalization | $23.58bn | Deal equals 10.0% |
| Estimated value lost | $1.39bn | 58.9% of deal price |
| 52-week high | $276.19 | Close is 34.4% lower |
Google Finance reported the close, range, share count and market value above. The $1.39 billion loss equals the $10.64 decline multiplied by 130.16 million shares. The $2.35 billion deal now represents about 10% of Verisk’s equity value.
The financing question matters. Verisk issued acquisition debt in 2025, then repaid $1.5 billion of principal in January. A revived closing would therefore require cash, new borrowing or both.
The original strategic case has not changed. “AccuLynx is a natural fit and extension of the solutions we provide insurance carriers, adjustors and contractors through our Property Estimating Solutions business,” Chief Executive Lee Shavel said when the deal was announced. Verisk acquisition announcement
AccuLynx connects roofing contractors with insurance claims workflows. Verisk expected the purchase to add to revenue growth and adjusted EBITDA margin. The original forecast called for adjusted EPS accretion by late 2026, a date now overtaken by the dispute.
| Latest operating measure | Q2 2026 | Year-on-year change |
|---|---|---|
| Revenue | $806m | +4.3% |
| Organic constant-currency revenue | Not stated in dollars | +5.8% |
| Adjusted EBITDA | $464m | +4.2% |
| Adjusted EPS | $1.98 | +5.3% |
| Operating cash flow | $366m | +49.7% |
| Free cash flow | $298m | +57.9% |
Verisk’s latest results show a cash-generative core business. The company kept its 2026 revenue outlook at $3.19 billion to $3.24 billion. Adjusted EPS guidance remains $7.45 to $7.75.
Capital allocation is less flexible than it looked. Verisk funded $1.9 billion of share repurchases during the first half at an average $186.32. Monday’s close was 2.8% below that average, while the revived purchase price exceeds those repurchases by $450 million.
| Analyst | Firm | Recommendation | Target | Date |
|---|---|---|---|---|
| Andrew Nicholas | William Blair | Buy, reiterated | Not listed | Aug. 10 |
| Ashish Sabadra | RBC Capital | Buy, maintained | $230 | Aug. 6 |
| Andrew Steinerman | J.P. Morgan | Buy, reiterated | $250 | July 30 |
| Jeffrey Meuler | Robert W. Baird | Buy, maintained | $247 | July 30 |
| Alex Kramm | UBS | Hold, maintained | $235 | July 30 |
| David Motemaden | Evercore ISI | Hold, maintained | $223 | July 30 |
| Toni Kaplan | Morgan Stanley | Hold, maintained | $235 | July 30 |
| George Tong | Goldman Sachs | Hold, maintained | $235 | July 29 |
| Faiza Alwy | Deutsche Bank | Hold, maintained | $225 | July 30 |
| Jason Haas | Wells Fargo | Buy, reiterated | $260 | July 30 |
| Curtis Nagle | Bank of America | Hold, maintained | $228 | July 29 |
| Manav Patnaik | Barclays | Buy, maintained | $275 | July 30 |
| Surinder Thind | Jefferies | Buy, upgraded | $235 | July 23 |
| Henry Hayden | Rothschild & Co Redburn | Hold, upgraded | $185 | June 18 |
The past three months produced seven buy and seven hold ratings, with no sells. Their average 12-month target is $235.62, 30.1% above Monday’s close. William Blair reiterated buy on Monday, but most published targets predate the court ruling.
Risks: FTC clearance is still uncertain, so Verisk could spend more without completing the purchase. A forced closing could raise leverage or reduce buybacks. Conversely, a successful appeal or negotiated exit could remove part of Monday’s discount.
The next decision point is not another earnings beat. Investors need the FTC path, Verisk’s legal response and a financing plan for a purchase equal to 10% of current market value.
